Molecular diagnostics has gained widespread recognition as a highly accurate and sensitive method for the early detection of infectious diseases, including COVID-19. This has resulted in increased adoption of molecular diagnostic tests by healthcare providers, and even common people becoming familiar with terms like RT-PCR. The report highlights the potential of molecular diagnostics to improve patient outcomes with predictive medicine, early diagnosis, and monitoring the efficacy of treatment modalities.

Click here to read the full article on ET Healthworld